These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2074511)

  • 1. Bladder cancer screening at the Dupont Chambers Works: a new initiative.
    Mason TJ; Vogler WJ
    J Occup Med; 1990 Sep; 32(9):874-7. PubMed ID: 2074511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New opportunities for screening and early detection of bladder cancer.
    Mason TJ; Walsh WP; Lee K; Vogler W
    J Cell Biochem Suppl; 1992; 16I():13-22. PubMed ID: 1305676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder cancer screening and monitoring of 4,4'-methylenebis(2-chloroaniline) exposure among workers in Taiwan.
    Chen HI; Liou SH; Loh CH; Uang SN; Yu YC; Shih TS
    Urology; 2005 Aug; 66(2):305-10. PubMed ID: 16098360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematuria screening for bladder cancer.
    Messing EM; Vaillancourt A
    J Occup Med; 1990 Sep; 32(9):838-45. PubMed ID: 2074507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening workers exposed to 4,4'-methylenebis(2-chloroaniline) for bladder cancer by cystoscopy.
    Ward E; Halperin W; Thun M; Grossman HB; Fink B; Koss L; Osorio AM; Schulte P
    J Occup Med; 1990 Sep; 32(9):865-8. PubMed ID: 2074509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for bladder cancer at the Du Pont Chambers Works: initial findings.
    Mason TJ; Prorok PC; Neeld WE; Vogler WJ
    J Occup Med; 1986 Oct; 28(10):1011-6. PubMed ID: 3772535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational bladder cancer: from cohort study to biologic molecular marker.
    Matsumoto K; Irie A; Satoh T; Kuruma H; Arakawa T; Baba S
    Med Sci Monit; 2005 Oct; 11(10):RA311-5. PubMed ID: 16192913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer screening program for a petrochemical cohort with potential exposure to beta-napthylamine.
    Felknor SA; Delclos GL; Lerner SP; Burau KD; Wood SM; Lusk CM; Jalayer AD
    J Occup Environ Med; 2003 Mar; 45(3):289-94. PubMed ID: 12661186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in screening protocols for the detection of early bladder cancer.
    Geller AC; Brooks DR; Barber CE; Koh HK; Lew RA; Wax S; Prout MN
    J Occup Med; 1990 Sep; 32(9):929-35. PubMed ID: 2074522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
    Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
    Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bladder cancer screening with urine-based tumour markers - occupational medical experience].
    Nasterlack M; Feil G; Leng G; Pesch B; Huber S; Sievert KD; Johnen G; Taeger D; Mayer T; Kluckert M; Brüning T; Stenzl A
    Aktuelle Urol; 2011 Mar; 42(2):128-34. PubMed ID: 21437837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational bladder cancer in textile dyeing and printing workers: six cases and their significance for screening programs.
    Frumin E; Velez H; Bingham E; Gillen M; Brathwaite M; LaBarck R
    J Occup Med; 1990 Sep; 32(9):887-90. PubMed ID: 2074514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
    BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Occupational bladder cancer in a 4,4 -methylenebis(2-chloroaniline) (MBOCA)-exposed worker.
    Liu CS; Liou SH; Loh CH; Yu YC; Uang SN; Shih TS; Chen HI
    Environ Health Perspect; 2005 Jun; 113(6):771-4. PubMed ID: 15929884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protocol for bladder cancer screening and medical surveillance among high-risk groups: the Drake Health Registry experience.
    Marsh GM; Callahan C; Pavlock D; Leviton LC; Talbott EO; Hemstreet G
    J Occup Med; 1990 Sep; 32(9):881-6. PubMed ID: 2074513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical follow-up for workers exposed to bladder carcinogens: the French evidence-based and pragmatic statement.
    Clin B; ; Pairon JC
    BMC Public Health; 2014 Nov; 14():1155. PubMed ID: 25377503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcome of patients with a negative work-up for asymptomatic microhematuria.
    Madeb R; Golijanin D; Knopf J; Davis M; Feng C; Fender A; Stephenson L; Messing EM
    Urology; 2010 Jan; 75(1):20-5. PubMed ID: 19913883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Drake Health Registry Study: findings from fifteen years of continuous bladder cancer screening.
    Marsh GM; Cassidy LD
    Am J Ind Med; 2003 Feb; 43(2):142-8. PubMed ID: 12541268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drake Chemical Workers' Health Registry Study: I. Notification and medical surveillance of a group of workers at high risk of developing bladder cancer.
    Marsh GM; Leviton LC; Talbott EO; Callahan C; Pavlock D; Hemstreet G; Logue JN; Fox J; Schulte P
    Am J Ind Med; 1991; 19(3):291-301. PubMed ID: 2008919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.